NCT07113184 Randomized a Clinical Trial With Medical Device in Acute Ischemic Stroke
| NCT ID | NCT07113184 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Instituto de Investigación Marqués de Valdecilla |
| Condition | Acute Ischemic Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 220 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 220 participants in total. It began in 2026-03-01 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to provide high-quality evidence on the potential benefits of the dual stentriever approach, potentially informing future clinical guidelines and improving outcomes in patients with anterior circulation large vessel occlusion strokes.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 * NIHSS ≥ 6 * mRS ≤ 1 * Proximal anterior circulation occlusion * ASPECTS \> 6 * Informed consent Exclusion Criteria: * Absence of occlusion * Posterior circulation stroke * Carotid dissection or tandem stenosis requiring treatment * Severe comorbidities or contraindications to imaging contrast
Frequently Asked Questions
Who can join the NCT07113184 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07113184 currently recruiting?
Yes, NCT07113184 is actively recruiting participants. Visit ClinicalTrials.gov or contact Instituto de Investigación Marqués de Valdecilla to inquire about joining.
Where is the NCT07113184 trial being conducted?
This trial is being conducted at Burgos, Spain, Málaga, Spain, Salamanca, Spain, Santander, Spain.
Who is sponsoring the NCT07113184 clinical trial?
NCT07113184 is sponsored by Instituto de Investigación Marqués de Valdecilla. The trial plans to enroll 220 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.